Can Serve Free LLC offers specialized investment advisory expertise to Clients who desire to understand oncology financial market dynamics and wisely build investment portfolios comprised of company stocks that fight Leukemia/Blood Cancer.
The Global Leukemia/Blood Cancer diagnostics market size was estimated at USD 10.21 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 6.8% from 2024 to 2030.
Leukemia is one of the most prevalent cancer types globally. The increasing demand for blood cancer diagnostic tests and technologies is driven by rising incidence of leukemia and other blood cancers worldwide. Next-Generation Sequencing (NGS) can help diagnose blood cancers, monitor treatment response, and identify potential therapeutic targets. Manufacturers are introducing platforms based on next-generation DNA sequencing technology, which are easy to use and can be integrated into clinical microbiology lab workflows.
Assay kits and reagents accounted for the largest revenue share of 72.12% in 2023. The increasing demand for accurate and rapid diagnostic tests is expected to drive the adoption of assay kits and reagents. Blood tests dominated the market and accounted for the largest share of 36.70% in 2023. The molecular tests segment is anticipated to grow at the fastest rate of 8.4% CAGR over the forecast period. Molecular tests have revolutionized the diagnosis and management of blood cancers by enabling the detection of genetic abnormalities and molecular markers associated with specific cancer types.
North America blood cancer diagnostics market dominated the global industry and accounted for a 38.13% share in 2023. The blood cancer diagnostics market in Europe was identified as a lucrative region in this industry. In addition, the blood cancer diagnostics market in Asia-Pacific is anticipated to witness the fastest growth over the forecast period. The blood cancer diagnostics market in Latin America is anticipated to grow at a substantial growth rate over the forecast period.
For additional information on Leukemia/Blood Cancer, please review the video Medical Centric.